These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8446175)

  • 1. [Lipopeptides as natural adjuvants for vaccines from Gram-negative bacteria].
    Schlecht S; Wiesmüller KH; Jung G; Bessler WG
    Naturwissenschaften; 1993 Jan; 80(1):9-17. PubMed ID: 8446175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of protection against Salmonella infection in mice mediated by a synthetic lipopeptide analogue of bacterial lipoprotein in S. typhimurium vaccines.
    Schlecht S; Wiesmüller KH; Jung G; Bessler WG
    Zentralbl Bakteriol; 1989 Oct; 271(4):493-500. PubMed ID: 2684208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein: tools for the standardization of in vitro assays.
    Bessler WG
    Dev Biol Stand; 1992; 77():49-56. PubMed ID: 1426672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization.
    Bessler WG; Heinevetter L; Wiesmüller KH; Jung G; Baier W; Huber M; Lorenz AR; Esche UV; Mittenbühler K; Hoffmann P
    Int J Immunopharmacol; 1997; 19(9-10):547-50. PubMed ID: 9637352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic lipopeptides as novel adjuvants.
    Bessler WG; Jung G
    Res Immunol; 1992 Jun; 143(5):548-53; discussion 579-80. PubMed ID: 1439136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization.
    Bessler WG; Baier W; vd Esche U; Hoffmann P; Heinevetter L; Wiesmüller KH; Jung G
    Behring Inst Mitt; 1997 Feb; (98):390-9. PubMed ID: 9382763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant.
    Bessler WG; Suhr B; Bühring HJ; Muller CP; Wiesmüller KH; Becker G; Jung G
    Immunobiology; 1985 Sep; 170(3):239-44. PubMed ID: 4054942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmonellosis of mice: some characteristics of a heat-treated Salmonella typhimurium vaccine.
    Jonas WE
    N Z Vet J; 1970 Sep; 18(9):177-81. PubMed ID: 4922502
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
    Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant.
    Wiesmüller KH; Jung G; Gillessen D; Loffl C; Bessler WG; Böltz T
    Immunology; 1991 Jan; 72(1):109-13. PubMed ID: 1705236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy) heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages, and adjuvanticity in vivo and in vitro.
    Metzger J; Jung G; Bessler WG; Hoffmann P; Strecker M; Lieberknecht A; Schmidt U
    J Med Chem; 1991 Jul; 34(7):1969-74. PubMed ID: 2066969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].
    Schlecht S; Westphal O
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes.
    Liu Q; Tan K; Yuan J; Song K; Li R; Huang X; Liu Q
    Int J Med Microbiol; 2018 Oct; 308(7):796-802. PubMed ID: 29970302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopeptides: adjuvanticity in conventional and genetic immunization.
    Mittenbühler K; v d Esche U; Heinevetter L; Bessler WG; Huber M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):193-200. PubMed ID: 12832125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against bacterial infection by urea extracts from Salmonella.
    Schlecht S; Mossmann H; Wiesmüller KH; Jung G; Bessler WG
    Zentralbl Bakteriol; 1996 Aug; 284(4):559-64. PubMed ID: 8899974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on oral adjuvants against murine salmonellosis.
    Ganguly R; Waldman RH; D'Alessandri R; Sutherland G
    Adv Exp Med Biol; 1978; 107():471-7. PubMed ID: 369314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to Salmonella infections.
    Cameron CM
    J S Afr Vet Assoc; 1976 Jun; 47(2):89-91. PubMed ID: 781241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
    Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
    Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro.
    Mittenbühler K; Loleit M; Baier W; Fischer B; Sedelmeier E; Jung G; Winkelmann G; Jacobi C; Weckesser J; Erhard MH; Hofmann A; Bessler W; Hoffmann P
    Int J Immunopharmacol; 1997 May; 19(5):277-87. PubMed ID: 9439766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.